<p>/PRNewswire/ -- Robbins LLP 提醒股东，代表所有在 2025 年 5 月 8 日至 2026 年 3 月 30 日期间购买或以其他方式获得 Phreesia, Inc. (NYSE: PHR) 普通股的投资者提起了集体诉讼。Phreesia 为美国和加拿大的医疗保健行业提供集成的基于 SaaS 的软件和支付平台。</p>
<p>如需更多信息，请提交表格，发送电子邮件给律师 Aaron Dumas, Jr.，或拨打电话 (800) 350-6003。</p>
<p><strong>指控：</strong> Robbins LLP 正在调查有关 Phreesia, Inc. (PHR) 误导投资者关于其网络解决方案业务增长可持续性和 2027 财年收入前景的指控。</p>
<p>根据投诉，在集体诉讼期间，被告未能披露以下事实：(1) Phreesia 在其网络解决方案部门的制药营销承诺正在减弱；(2) 公司对制药制造商未来支出承诺的可见性降低；(3) 网络解决方案客户在 2027 财年下半年的支出承诺低于公司之前的预期；(4) 网络解决方案收入预测的变动性增加，使公司的 2027 财年收入指引和长期增长前景面临风险。</p>
<p>原告声称，在 2026 年 3 月 30 日，Phreesia 宣布将其 2027 财年收入前景下调至 5.1 亿至 5.2 亿美元，低于之前的 5.45 亿至 5.59 亿美元的范围。公司披露其正在经历来自某些制药制造商的 “支出承诺可见性缩短”，并且网络解决方案客户在 2027 财年下半年的支出承诺低于预期。公司进一步表示，“我们内部网络解决方案收入预测的变动性现在更大。” 在随后的财报电话会议上，被告进一步披露，由于 “品牌特定动态，包括监管政策的影响”，某些客户的营销支出减少。受此消息影响，Phreesia 的股价从 2026 年 3 月 30 日的每股 11.41 美元跌至 2026 年 3 月 31 日的每股 8.38 美元，下降约 27%。</p>
<p><strong>接下来怎么办</strong>：您可能有资格参与对 Phreesia, Inc. 的集体诉讼。希望担任集体诉讼主诉人的股东必须在 2026 年 7 月 13 日之前向法院提交相关文件。主诉人是代表其他集体成员指导诉讼的代表方。您不必参与案件即可有资格获得赔偿。如果您选择不采取任何行动，您可以保持缺席集体成员身份。如需更多信息，请点击此处。</p>
<p><strong><em>所有代理均按成功收费基础进行。股东无需支付任何费用或开支。</em></strong></p>
<p><strong>关于 Robbins LLP</strong>：作为股东权益诉讼的公认领导者，Robbins LLP 的律师和员工自 2002 年以来一直致力于帮助股东追回损失、改善公司治理结构，并追究公司高管的错误行为。</p>
<p>如果您希望在对 Phreesia, Inc. 的集体诉讼达成和解时收到通知，或在公司高管从事不当行为时免费接收警报，请立即注册 Stock Watch。</p>
<p>律师广告。过去的结果并不保证类似的结果。</p>
<p>来源 Robbins LLP</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTE0Jk5ld3NJdGVtSWQ9TEE2MDM2NyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTQxODM1UFJfTkVXU19VU1BSX19fX19MQTYwMzY3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTE0Jk5ld3NJdGVtSWQ9TEE2MDM2NyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTQxODM1UFJfTkVXU19VU1BSX19fX19MQTYwMzY3"/></p>

<p>Robbins LLP 宣布对在 2025 年 5 月 8 日至 2026 年 3 月 30 日期间购买 Phreesia, Inc.（纽约证券交易所代码：PHR）股票的投资者提起集体诉讼。诉讼指控 Phreesia 误导投资者关于其网络解决方案业务的增长可持续性及其 2027 财年的收入前景。在收入前景下调后，Phreesia 的股价下跌了约 27%。有意参与集体诉讼的股东必须在 2026 年 7 月 13 日之前提交相关文件</p>

<p>, /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Phreesia, Inc. (NYSE: PHR) common stock between May 8, 2025 and March 30, 2026. Phreesia provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.</p>
<div class="lb-trans"><p>/PRNewswire/ -- Robbins LLP 提醒股东，代表所有在 2025 年 5 月 8 日至 2026 年 3 月 30 日期间购买或以其他方式获得 Phreesia, Inc. (NYSE: PHR) 普通股的投资者提起了集体诉讼。Phreesia 为美国和加拿大的医疗保健行业提供集成的基于 SaaS 的软件和支付平台。</p>
</div><p>For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.</p>
<div class="lb-trans"><p>如需更多信息，请提交表格，发送电子邮件给律师 Aaron Dumas, Jr.，或拨打电话 (800) 350-6003。</p>
</div><p><strong>The Allegations:</strong> Robbins LLP is Investigating Allegations that Phreesia, Inc. (PHR) Misled Investors Regarding the Sustainability of Growth in its Network Solutions Business and Fiscal 2027 Revenue Outlook</p>
<div class="lb-trans"><p><strong>指控：</strong> Robbins LLP 正在调查有关 Phreesia, Inc. (PHR) 误导投资者关于其网络解决方案业务增长可持续性和 2027 财年收入前景的指控。</p>
</div><p>According to the complaint, during the class period, defendants failed to disclose that: (1) Phreesia's pharmaceutical marketing commitments within its Network Solutions segment were weakening; (2) the Company was experiencing reduced visibility into future spending commitments from pharmaceutical manufacturers; (3) Network Solutions clients were committing lower spending levels for the second half of fiscal year 2027 than the Company had previously anticipated; and (4) increasing variability in Network Solutions revenue forecasting placed the Company's fiscal year 2027 revenue guidance and long-term growth outlook at risk.</p>
<div class="lb-trans"><p>根据投诉，在集体诉讼期间，被告未能披露以下事实：(1) Phreesia 在其网络解决方案部门的制药营销承诺正在减弱；(2) 公司对制药制造商未来支出承诺的可见性降低；(3) 网络解决方案客户在 2027 财年下半年的支出承诺低于公司之前的预期；(4) 网络解决方案收入预测的变动性增加，使公司的 2027 财年收入指引和长期增长前景面临风险。</p>
</div><p>Plaintiff alleges that on March 30, 2026, Phreesia announced that it was lowering its fiscal year 2027 revenue outlook to a range of $510 million to $520 million from a previous range of $545 million to $559 million. The Company disclosed that it was experiencing &#34;shorter visibility into spending commitments&#34; from certain pharmaceutical manufacturers and that Network Solutions clients were committing lower spending levels for the second half of fiscal year 2027 than anticipated. The Company further stated that &#34;there is now more variability in our internal network solutions revenue forecasting.&#34; On the accompanying earnings call, defendants further disclosed that certain clients were committing fewer marketing dollars due to &#34;brand-specific dynamics including the impact of regulatory policies.&#34; On this news, Phreesia's stock price fell from $11.41 per share on March 30, 2026, to $8.38 per share on March 31, 2026, a decline of approximately 27%.</p>
<div class="lb-trans"><p>原告声称，在 2026 年 3 月 30 日，Phreesia 宣布将其 2027 财年收入前景下调至 5.1 亿至 5.2 亿美元，低于之前的 5.45 亿至 5.59 亿美元的范围。公司披露其正在经历来自某些制药制造商的 “支出承诺可见性缩短”，并且网络解决方案客户在 2027 财年下半年的支出承诺低于预期。公司进一步表示，“我们内部网络解决方案收入预测的变动性现在更大。” 在随后的财报电话会议上，被告进一步披露，由于 “品牌特定动态，包括监管政策的影响”，某些客户的营销支出减少。受此消息影响，Phreesia 的股价从 2026 年 3 月 30 日的每股 11.41 美元跌至 2026 年 3 月 31 日的每股 8.38 美元，下降约 27%。</p>
</div><p><strong>What Now</strong>: You may be eligible to participate in the class action against Phreesia, Inc. Shareholders who wish to serve as lead plaintiff for the class must submit their papers with the court by July 13, 2026. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.</p>
<div class="lb-trans"><p><strong>接下来怎么办</strong>：您可能有资格参与对 Phreesia, Inc. 的集体诉讼。希望担任集体诉讼主诉人的股东必须在 2026 年 7 月 13 日之前向法院提交相关文件。主诉人是代表其他集体成员指导诉讼的代表方。您不必参与案件即可有资格获得赔偿。如果您选择不采取任何行动，您可以保持缺席集体成员身份。如需更多信息，请点击此处。</p>
</div><p><strong><em>All representation is on a contingency fee basis. Shareholders pay no fees or expenses.</em></strong></p>
<div class="lb-trans"><p><strong><em>所有代理均按成功收费基础进行。股东无需支付任何费用或开支。</em></strong></p>
</div><p><strong>About Robbins LLP</strong>: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002.</p>
<div class="lb-trans"><p><strong>关于 Robbins LLP</strong>：作为股东权益诉讼的公认领导者，Robbins LLP 的律师和员工自 2002 年以来一直致力于帮助股东追回损失、改善公司治理结构，并追究公司高管的错误行为。</p>
</div><p>To be notified if a class action against Phreesia, Inc settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.</p>
<div class="lb-trans"><p>如果您希望在对 Phreesia, Inc. 的集体诉讼达成和解时收到通知，或在公司高管从事不当行为时免费接收警报，请立即注册 Stock Watch。</p>
</div><p>Attorney Advertising. Past results do not guarantee a similar outcome.</p>
<div class="lb-trans"><p>律师广告。过去的结果并不保证类似的结果。</p>
</div><p>SOURCE Robbins LLP</p>
<div class="lb-trans"><p>来源 Robbins LLP</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTE0Jk5ld3NJdGVtSWQ9TEE2MDM2NyZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTQxODM1UFJfTkVXU19VU1BSX19fX19MQTYwMzY3" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA60367&amp;Transmission_Id=202605141835PR_NEWS_USPR_____LA60367&amp;DateId=20260514"/></p>

18:35 ETPHR 股东提醒：股东权利律师事务所 Robbins LLP 提醒投资者注意针对 Phreesia, Inc. 的证券集体诉讼案件